<DOC>
	<DOCNO>NCT01506752</DOCNO>
	<brief_summary>The purpose study investigate bioequivalence improve current orally disintegrate E2020 10 mg tablet single dose Japanese healthy adult male two administration method ( with/without water ) .</brief_summary>
	<brief_title>A Bioequivalence Study Comparing Improved Versus Current Orally Disintegrating E2020 10 mg Tablet Healthy Japanese Adult Males</brief_title>
	<detailed_description />
	<mesh_term>Donepezil</mesh_term>
	<criteria>Inclusion Criteria Those meet criterion eligible enroll study ; 1 . Those provide consent . 2 . Male subject age â‰¥ 20 year &lt; 45 year old time obtain informed consent nonsmoker ( subject smoke least 4 week prior study treatment ) 3 . BMI screen 18.5 kg/m2 less 25.0 kg/m2 4 . Those willing comply condition describe study protocol . Exclusion Criteria Those meet criterion exclude study . 1 . Any significant medical illness require intervention within 8 week treatment , medical history clinically significant infectious disease within 4 week treatment . 2 . Those psychiatric , GI tract , hepatic , renal , respiratory , endocrine , hematological , neurological , cardiovascular disease congenital metabolic disorder within 4 week study drug administration may impact evaluation drug . 3 . Subjects medical history GI , hepatic , renal surgery ( e.g . excision liver , kidney GI tract ) may impact pharmacokinetics drug . 4 . Subjects history medically significant allergy medication food , currently symptoms seasonal 5 . Subjects whose weight change 10 % screen phase study drug administration . 6 . Those clinical abnormal symptom , medical history organ dysfunction , subjective symptom , objective finding , vital sign , abnormal EKG clinical laboratory test value , need medical intervention . 7 . Corrected change QT wave ( QTc ) interval &gt; 450 msec 12lead EKG screen study drug administration . 8 . Subjects positive hepatitis B surface antigen ( HBs antigen ) , hepatitis C ( HCV ) antibody , serologic test syphilis ( STS ) . 9 . Subjects suspect history drug alcohol abuse , positive urine screen drug abuse exhalation alcohol test screening baseline . 10 . Subjects consume caffeinecontaining food beverage within 72 hour study drug administration . 11 . Exposure supplement herbs ( include Chinese medicine ) , beverage ( e.g . alcohol grapefruitcontaining beverage , within 2 week study drug administration . 12 . Exposure St. John 's wort containing medication within 4 week study drug administration . 13 . Use prescription drug within 4 week study drug administration . 14 . Use OTC medication within 2 week study drug administration . 15 . Subjects enrol another clinical trial expose investigational drug within 16 week study enrollment . 16 . Subjects receive blood infusion within 12 week , blood drawn 400 mL within 12 week , 400 mL , 200 mL within 4 week , sample component blood within 2 week study drug administration . 17 . Subjects perform extreme exercise exhaust labor ( 1 hr/day 5 day/week ) within 2 week hospitalization . 18 . Any subject , whose partner , want take highly reliable contraceptive measure end posttreatment examination . 19 . Subjects inappropriate participate study , judge investigator subinvestigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Healthy Subjects</keyword>
	<keyword>Donepezil</keyword>
</DOC>